[Extrahepatic cholestasis: the echographic and CT findings]

Extrahepatic cholestasis remains a diagnostic challenge due to overlapping symptoms and imaging limitations. Prior research has shown that jaundice often stems from biliary obstruction, but distinguishing the exact cause remains difficult. Ultrasound has been widely used for initial assessment, though its limitations in certain anatomical regions are well documented. Computerized tomography has also been applied, but its comparative advantages and drawbacks are less clear. The need for precise imaging guidance to identify obstruction locations has driven recent investigations. No prior work had resolved the relative strengths of ultrasound and CT in specific tumor types. This gap motivated a study to compare diagnostic accuracy across modalities. The uncertainty around which method best identifies obstruction levels prompted this prospective analysis.

This study aimed to compare the diagnostic accuracy of ultrasound and computerized tomography in detecting extrahepatic cholestasis. The specific problem addressed was the variability in imaging sensitivity across different obstruction sites and tumor types. The motivation stemmed from the need to guide clinical decisions on imaging modality selection. The study focused on identifying which method better detects biliary duct dilation and obstruction levels. It also sought to determine which modality excels in diagnosing specific tumors like cholangiocarcinoma. The goal was to provide evidence-based guidance for diagnostic imaging protocols. The researchers proposed that ultrasound might outperform CT in certain contexts. The study aimed to clarify these comparative strengths to improve patient outcomes.

The study enrolled 150 patients with jaundice and suspected extrahepatic cholestasis. Each participant underwent clinical history assessment, laboratory tests, and ultrasound imaging. Computerized tomography was performed in a subset of 46 patients. The diagnostic performance of both imaging methods was evaluated for detecting biliary duct dilation. Sensitivity was calculated for each modality in identifying obstruction levels. The researchers compared the accuracy of ultrasound and CT in diagnosing specific tumor types. Data were analyzed to determine which method had higher sensitivity in different anatomical regions. The study design allowed direct comparison of diagnostic outcomes between the two imaging techniques. The approach ensured a prospective assessment of imaging accuracy in real-world clinical scenarios.

Ultrasonography detected biliary duct dilation with a sensitivity of 92.6%, compared to 87.2% for computerized tomography. Computerized tomography identified obstruction levels with 89.1% sensitivity, particularly at suprapancreatic and ampullary sites. Ultrasound had 80% sensitivity for determining obstruction levels. For cholangiocarcinoma, ultrasound showed 77% sensitivity versus 77% for CT. Gallbladder carcinoma was detected with 100% sensitivity by ultrasound. CT demonstrated 83% sensitivity for choledocholithiasis and 75% for ampullary carcinoma. Both methods had equal accuracy for pancreatic carcinoma (87%) and pancreatitis (88%). These findings suggest ultrasound may be superior in certain tumor types.

The authors propose that ultrasound has higher sensitivity than CT in detecting biliary duct dilation and gallbladder carcinoma. They suggest CT may be more accurate for choledocholithiasis and ampullary carcinoma. The findings indicate that ultrasound excels in identifying obstruction levels at certain anatomical sites. The study supports the use of ultrasound as a first-line diagnostic tool in specific clinical contexts. The authors suggest that CT remains valuable for certain tumor types and obstruction levels. The results trace directly to the observed sensitivities in the study population. No essentiality is assigned to any modality beyond the authors' stated observations. The conclusions reflect the comparative diagnostic accuracy reported in the abstract.